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The C. elegans vulva is patterned by epidermal
growth factor (EGF) activation of Ras to control 1
fate, and 1 fate induces antagonistic Notch-depen-
dent 2 fate. Furthermore, a spatial EGF gradient, in
addition to inducing 1 fate, directly contributes to
2 fate via an unknown pathway. We find that in
addition to its canonical effector, Raf, vulval Ras
utilizes an exchange factor for the Ral small GTPase
(RalGEF), such that Ras-RalGEF-Ral antagonizes
Ras-Raf pro-1 fate activity. Consistent with its
restricted expression pattern, Ral participates in
EGF pro-2 activity. Thus, we have delineated a Ras
effector-switching mechanism whereby position
within the morphogen gradient dictates that Ras
effector usage is switched to RalGEF from Raf to
promote 2 instead of 1 fate. Our observations
define the utility of Ras effector switching during
normal development and may provide a possible
mechanistic basis for cell and cancer-type differ-
ences in effector dependency and activation.
INTRODUCTION
An emerging complexity of mammalian Ras-signal transduction
is the assortment of catalytically diverse effectors that may facil-
itate the elaborate biological activities of Ras in normal and
neoplastic cells. The precise role that each effector serves,
dynamic regulation of effector utilization, and interplay between
effector networks are issues that remain poorly understood.
Analysis of C. elegans vulval development has provided key
insights into Ras-signaling components and concepts con-
served in mammalian cells. The vulval precursor cells (VPCs)
are a developmental equivalence group of six ventral epithelial
cells (P3.p–P8.p) (Sternberg, 2005) (Figure 1A). The nearby
anchor cell (AC) induces VPCs to assume a highly reproducible
3-3-2-1-2-3 pattern of fates. The AC-proximal VPC is
induced to assume the 1 fate, flanking VPCs assume the 2
fate, and distal uninduced VPCs assume the nonvulval 3 fate.
Along with studies in other systems, analyses of the pro-1 AC
inductive signal were instrumental in delineating the first signal84 Developmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier Intransduction pathway connecting the cell surface to the nucleus
(Egan and Weinberg, 1993). The AC secretes LIN-3/EGF
(epidermal growth factor), which promotes LET-60/Ras activa-
tion of the LIN-45/Raf-MEK-ERK mitogen-activated protein
kinase (MAPK) signaling cascade to regulate the LIN-1 (Ets)
and LIN-31 (HNF) transcription factors, thereby inducing 1
fate (Sundaram, 2006) (Figure 1B). Analogously to human
cancers, mutational activation of LET-60/Ras promotes ERK
activation, leading to excess vulval induction (Figures 2A and
2B), whereas loss of pathway components results in vulval
absence. All constituents of this signaling pathway, particularly
LET-60/Ras, are strongly conserved (see Figure S1C available
online). This degree of conservation argued, prematurely, that
our understanding of Ras effector signaling was complete.
However, subsequent mammalian cell studies characterized
additional Ras effectors, with now at least ten distinct functional
classes identified (Repasky et al., 2004). With many effectors
expressed ubiquitously, an unresolved issue is how Ras effector
utilization is orchestrated to facilitate the complex biological
outputs of Ras.
Recent analyses have implicated the guanine nucleotide
exchange factor for the Ral GTPase (RalGEF) as an effector of
importance comparable to Raf in Ras-dependent human onco-
genesis (Chien and White, 2003; Hamad et al., 2002). Like Ras,
Ral functions as a GDP/GTP-regulated switch. Because RalGEF
and Ral are conserved inC. elegans, EGF activation of Ras could
involve the RalGEF-Ral pathway in regulation of vulval cell fate.
Two competing models have been proposed to illustrate the
mechanisms of vulval fate patterning. The original ‘‘morphogen
gradient model’’ proposes that a LIN-3/EGF, AC-maximal
concentration gradient differentially patterns VPCs dictated by
proximity to the AC (Katz et al., 1995, 1996; Sternberg and Hor-
vitz, 1986, 1989). This model posits that whereas strong EGF
signal induces 1 fate, diminished EGF signal directly promotes
2 fate for more distal VPCs. Appropriately, an ERK-responsive
1 fate reporter was highly expressed in the presumptive 1
VPC, with transient low expression in presumptive 2 VPCs
(Yoo et al., 2004), but further mechanistic support is lacking.
In contrast the ‘‘sequential induction model’’ proposes that
EGF induces only the most proximal VPC, which becomes 1.
Subsequently, this presumptive 1 cell expresses DSL ligands
that, via the LIN-12/Notch receptor, laterally induce neighboring
VPCs to assume 2 fate (Chen and Greenwald, 2004). Accord-
ingly, the LET-23/EGF receptor (EGFR) is necessary for 1 but
not 2 fate induction (Koga and Ohshima, 1995; Simske andc.
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Figure 1. An Overview of VPC Patterning
(A) A graded EGF signal from the AC induces vulval fates. High EGF levels (black arrow) activate the EGFR-Ras-Raf pathway in P6.p to induce 1 fate. Lateral
signal (gray arrows) from the presumptive 1 cell activates LIN-12/Notch in P5.p and P7.p to induce 2 fate. 1 and 2 descendents form the vulva; 3 VPCs are
nonvulval. Low EGF levels (dashed arrows) may help pattern P5.p and P7.p. (B) The EGF-Ras-MAP kinase signal transduction pathway specifies 1 cell fate.
(C) Sequence alignment ofHomo sapiens (H.s.) RalA andRalB,Drosophilamelanogaster (D.m.) Ral, andCaenorhabditis elegans (C.e.) RAL-1. Identical and similar
residues are marked with black and gray shading, respectively. Residues S31 (mutated to N for dn) and Q75 (mutated to L for gf) are shown by arrows. The core
effector domain is boxed in solid lines, and the C-terminal hypervariable and CAAX prenylation signal motif region in dashed lines.
See also Figure S1.
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Ral in Vulval PatterningKim, 1995), and pro-1 EGF and pro-2 Notch pathways
together are necessary and sufficient to generate initial commit-
ment to the 2-1-2 fate pattern (Greenwald, 2005; Sternberg,
2005). However, the ‘‘sequential induction model’’ and the
‘‘morphogen gradient model’’ have yet to be mechanistically
reconciled.DeveImportantly, 1 and 2 fates are mutually antagonistic; via
‘‘quenching’’ mechanisms inappropriate pathway activities are
reduced to minimize conflicting pro-1 and pro-2 signals in
the same cell. Presumptive 1 cells enact programs that antago-
nize pro-2 signaling (Levitan and Greenwald, 1998; Yoo and
Greenwald, 2005), and conversely presumptive 2 cells enactlopmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier Inc. 85
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Figure 2. RAL-1 Antagonizes LET-60-
Dependent Vulval Induction
(A and B) DIC micrographs of (A) WT and (B) let-60
(n1046gf); gfp(RNAi) animals as late L4 larvae.
Bars indicate the typical 2-1-2 vulva, and the
arrow indicates a pseudovulva. Anterior is left,
and ventral is down. (C) rgl-1(RNAi) or ral-1(RNAi)
enhanced let-60(n1046gf) hyper-induction. Nega-
tive controls were gfp(RNAi) and lin-3/EGF(RNAi),
and the positive control was gap-1/RasGAP
(RNAi). Data shown are representative of six inde-
pendent assays. (D) The ral-1 deletion, tm2760,
enhanced let-60(n1046gf). The n1046 single
mutant was counted in nine assays, the double
mutant in four. (E) Transgenic dominant-negative
RAL-1(S31N) enhanced let-60(gf). Two trans-
genes were analyzed; that shown was assayed
three times, another four. (F) Transgenic-activated
RAL-1(Q75L) suppressed let-60(gf). One trans-
gene was assayed seven times. y axis is the
number of VPCs induced to vulval (1 and 2) fates.
Data are the mean ± standard error of the mean
(SEM). For statistical reasons single, nonpooled
assays are shown, and white numbers represent
animals scored therein. Statistics were calculated
by Kruskal-Wallis, Dunn test (C), or Mann-Whitney
test (D–F).
See also Figure S2.
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Ral in Vulval Patterningprograms that antagonize pro-1 signaling (Berset et al., 2001;
Berset et al., 2005; Yoo et al., 2004). For example the LIP-1
ERK protein phosphatase is expressed in presumptive 2 line-
ages to quench ERK signaling. Thus, the developmental conse-
quences of EGF activation of Ras-Raf signaling in 2 lineages
may be minimal, and pro-2 EGF activity mediated through
distinct effector pathways.
The most plausible composite model for robust vulval
patterning would be one that reconciles these three evidence-
based models: graded morphogen signaling, sequential induc-
tion, and pathway quenching. Yet, to our knowledge, nothing
is known about themechanism of the putative pro-2 EGF signal.
Despite decades of research into how a single morphogen
gradient can induce multiple cell fates, there are few instances
in which the mechanism of such differential inductions is under-
stood (Piddini and Vincent, 2009).
In this study we identify a mechanism for EGF pro-2 signaling
and, thus, reconcile the three features of vulval patterning into
a unified model. We show that during vulval patterning, Ras
through Raf transduces a pro-1 signal, then through the Ral-86 Developmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier Inc.GEF-Ral pathway transduces a pro-2
signal. Ral signaling antagonizes Raf
and regulates the balance of 1 and 2
fates. Ral is necessary and sufficient to
drive maximal Notch pro-2 activity, and
the RalGEF-Ral pathway is quenched in
presumptive 1 cells by restricted Ral
expression. In summary our study estab-
lishes that Ras effector utilization is
controlled to signal for distinct cellular
outcomes. Therefore, analogous mecha-
nisms may contribute to the distinct
patterns of effector utilization that occur in different settings of
mutant Ras-driven human cancers.
RESULTS
C. elegans Contains Single RalGEF and Ral Orthologs
The C. elegans genome contains single RalGEF (rgl-1; F28B4.2)
and Ral (ral-1; Y53G8AR.3) genes. rgl-1 encodes predicted
splice variants producing proteins of 860 and 880 residues that
share the identical domain architecture with human Ras-GTP
Association (RA) domain-containing RalGEFs: an N-terminal
Ras Exchange Motif (REM), a central CDC25 homology (Ras-
GEF) catalytic domain, and aC-terminal RA domain (Figure S1A).
ral-1 encodes a predicted protein of 213 residues consisting of a
GTPase domain and C-terminal membrane-targeting sequence
sharing strong sequence identity (61%–65%) with human RalA
and RalB (Figure 1C; Figure S1B). The effector-binding regions
of human and C. elegans Ral GTPases share high identity,
suggesting common effector utilization; Ral effector orthologs
are also conserved in C. elegans. The strong conservation of
Developmental Cell
Ral in Vulval Patterningthe RalGEF effector pathway components suggests an impor-
tant role in C. elegans LET-60/Ras function.
RGL-1-RAL-1 Antagonizes Ras-Raf in Ras-Mediated
Vulval Development
Genetic dissection of LET-60/Ras signaling in vulval develop-
ment was instrumental in delineating the Raf-MEK-ERK pathway
in mammalian cells. Consequently, we used multiple genetic
approaches to dissect the role of RGL-1 and RAL-1 in Ras-
directed vulval development. In a moderately activating gain-
of-function (gf) LET-60 background (let-60 allele n1046; G13E
mutation), we introduced rgl-1(RNAi) or ral-1(RNAi). Unexpect-
edly, we found increased, rather than decreased, vulval hyper-
induction (Figure 2C). Negative control RNAi targeting gfp (green
fluorescent protein) and lin-3 (encoding EGF, acting upstream)
had no effect, whereas positive control RNAi targeting gap-1 (en-
coding RasGAP, a negative regulator of LET-60 activity)
enhanced the let-60(gf) phenotype. rgl-1 or ral-1 knockdown in
a wild-type (WT) background caused no defect (data not shown),
suggesting a modulatory role for RGL-1-RAL-1 signaling.
A caveat is that the RGL-1/RAL-1-dependent phenotypes
could be specific to let-60(n1046gf), e.g., if the in situ-activating
mutation conferred inappropriate LET-60/Ras utilization of
RGL-1. We ruled out this concern by showing that rgl-1(RNAi)
and ral-1(RNAi) enhanced vulval hyper-induction due to LIN-3/
EGF overexpression, an activating LET-23/EGFR mutation, and
a transgene expressing activated LIN-45/Raf, and suppressed
the under-induced phenotype conferred by reduced function
mutations (rf) in lin-3/EGF or let-23/EGFR (Figures S2A–S2E).
To corroborate these RNAi results with an independent meth-
odology, we also analyzed a ral-1 deletion (D), tm2760, which re-
moves a portion of intron 3, including the splice donor site.
Presumably intron 3 splicing is blocked, resulting in strong loss
of function. ral-1(D) enhanced the let-60(gf) hyper-induced
phenotype (Figure 2D).
Dominant-negative (dn) RAL-1(S31N), predicted to sequester
and inactivate its GEF (Urano et al., 1996), should also enhance
activated LET-60-driven pro-1 activity. We generated let-60(gf)
animals harboring ral-1(dn) driven by the VPC-specific lin-31
promoter (Plin-31) (Tan et al., 1998). The hyper-induced vulval
phenotype of let-60(gf) animals expressing RAL-1(dn) was
enhanced compared to nontransgenic siblings (Figure 2E). In
contrast, VPC-specific expression of RAL-1(gf) (Q75L) sup-
pressed the hyper-induced vulval phenotype of let-60(gf)
animals relative to their nontransgenic siblings (Figure 2F),
whereas RAL-1(gf) caused no defect in a WT background (data
not shown). Control VPC-specific expression of WT RAL-1 did
not alter the let-60(gf) phenotype, indicating that our VPC
expression system is phenotypically neutral (data not shown).
Taken together, these data support four conclusions. First,
RGL-1 and RAL-1 antagonize the canonical Ras-Raf-MEK-
ERK pro-1 signal. Second, RGL-1 and RAL-1 function compa-
rably in vulval patterning and likely comprise a RGL-1-RAL-1
signaling module. Third, RGL-1 and RAL-1 function cell autono-
mously in VPCs. Fourth, neither loss nor gain of RGL-1 or RAL-1
function in a WT background perturbed vulval patterning, sug-
gesting that RGL-1 and RAL-1 are not part of core pro-1 or
pro-2 induction pathways but rather are modifiers of LET-
60/Ras stimulated vulval patterning signals. Other comparableDevepathway modifiers, both positive and negative, have been iden-
tified in sensitized genetic screens. Perturbation of these genes
caused no phenotype alone, but collectively, they exert
a profound influence on vulval patterning (Berset et al., 2001;
Berset et al., 2005; Sundaram, 2006; Yoo et al., 2004; Yoo and
Greenwald, 2005).
RAL-1 Contributes to the 1/2Fate Decision
To evaluate directly whether disruption of ral-1 perturbs cell fate
specification,weusedaPegl-17::cfp-LacZ transgeneas a reporter
of 1 cell fate (Yoo et al., 2004). Notch-dependent lateral signal
normally prevents formation of neighboring 1 cells. However,
when the 1/2 signaling balance is genetically disrupted to favor
1 fate, the frequency of neighboring 1 lineages increases (Ber-
set et al., 2001; Berset et al., 2005; Yoo et al., 2004). In a let-60(gf)
background, ral-1(RNAi) increased significantly the number of
adjacent CFP-positive lineages (Figures 3A–3C; Figures S3A–
S3C). Because gfp-directed RNAi inhibits CFP expression,
daf-3(RNAi) rather than gfp(RNAi) was validated and used as
a negative control (Figure S3D). We conclude that RAL-1 activity
promotes 2 fate at the expense of 1 fate, either indirectly by
antagonizing 1 fate, or directly by promoting 2 fate.
LET-60/Ras Mediates Genetically Separable Pro-1
and Antagonistic Signals
RGL-1 was identified previously in a yeast two-hybrid screen
with activated LET-60 bait, but further characterization was not
pursued (Shibatohge et al., 1998). We hypothesize that LET-
60/Ras binds and activates RGL-1 to antagonize the Ras-Raf
pro-1 signal, and thus, under certain conditions loss of LET-
60/Ras should be functionally equivalent to loss of RGL-1 and
RAL-1. However, LET-60/Ras activation of LIN-45/Raf is an
essential event during vulval induction, so we could not directly
assess the necessity of LET-60 for RGL-1 activation. To address
this question we used hyper-inducing mutations in downstream
genes, thought to be independent of upstream Ras-Raf-MEK-
ERK activity. In vulval induction the principal pro-1 transcription
factors are inhibited by ERK. Consequently, the lin-31(n301) null
mutation (‘‘0’’) and the lin-1(e1275ts) ‘‘rf’’ confer moderate hyper-
induction. RNAi targeting lin-45/Raf and mpk-1/ERK had no
effect on hyper-induction, indicating that lin-31(0) and lin-1(rf)
are Raf-MEK-ERK independent. lin-45/Raf and mpk-1/ERK
RNAi were validated separately for activity (Figures S3D–S3F;
data not shown). In contrast RNAi of let-60, rgl-1 or ral-1
enhanced the lin-31(0) and lin-1(rf) hyper-induced phenotypes
(Figures 3D and 3E), suggesting that LET-60/Ras functions
similarly to RGL-1-RAL-1 in antagonizing Ras-Raf and that this
signal functions parallel to or downstream of LIN-31/LIN-1 tran-
scription factors. We also repeated this result with mutations;
partial loss of let-60/Ras but not lin-45/Raf enhanced lin-31(0)
(Figure 3F). These data further suggest that in addition to the
canonical pro-1 Ras signal through Raf-MEK-ERK, Ras also
signals through RGL-1-RAL-1 to antagonize Ras-Raf.
Ectopic LET-60/Ras Is Sufficient to InduceRGL-1-RAL-1
Activity
LET-60 shares 73%–77% identity with human Ras proteins, with
100% identity in the core effector-binding domain (32–40;
Figure S1C). To assess whether Ras is sufficient to activatelopmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier Inc. 87
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Figure 3. Ras-RGL-1-RAL-1 Bypasses Ras-Raf to Control Cell Fate
(A and B) Expression of Pegl-17::cfp-lacZ in VPC daughters. Overlaid DIC and CFP fluorescence images of (A) let-60(n1046gf); daf-3(RNAi) and (B) let-60(gf); ral-1
(RNAi) at the Pn.px stage. The black bar indicates P6.px, and white bar indicates P7.px cells. (C) Percent L3 larvae with CFP-positive lineages neighboring the
P6.p lineage (P5.p or P7.p derived) at the Pn.px stage in the let-60(gf); arIs92 (Pegl-17::cfp-lacZ) background. Shown are average percentages of animals with
adjacent 1 cell fate from three independent assays ±SEM. The numbers of adjacent 1 cells out of the total per assay were: for daf-3(RNAi) 3/25, 6/26, and
6/30; for ral-1(RNAi) 17/27, 19/29, and 18/30; and for lin-12(RNAi) 12/17 and 20/28. White numbers represent pooled total animals scored. (D) let-60-, rgl-1-,
and ral-1-directed RNAi enhanced the hyper-inducing lin-31(n301). gfp, gap-1, lin-45, and mpk-1 RNAi controls were negative. Data shown are representative
of three independent assays. (E) lin-12-, let-60-, rgl-1-, and ral-1-directed RNAi enhanced the hyper-inducing lin-1(e1275ts) at 23C. gfp, gap-1, lin-45, andmpk-1
RNAi controls were negative. Data shown are representative of three independent assays. (F) let-60(n2021rf) but not lin-45(sy96rf) enhanced the hyper-inducing
lin-31(n301). Data shown are representative of four independent assays. (G) Transgenic-activated LET-60(12V,37G) (RalGEF selective) suppressed let-60
(n1046gf) compared to nontransgene-bearing siblings and was RGL-1 and RAL-1 dependent. Two transgenes were assayed three times each. y axis is the
number of VPCs induced to vulval (1 and 2) fates. Data are the mean ± SEM. For statistical reasons single, nonpooled assays are shown, and white numbers
represent animals scored therein. Statistics were calculated by Fisher’s exact test (C) or Kruskal-Wallis, Dunn test (D–G).
See also Figure S3.
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Ral in Vulval PatterningRGL-1, we used mutationally activated LET-60 (let-60(12V)) with
missense mutations that result in differentially impaired effector
binding. The E37G mutation retains effective interaction with
RalGEF, but not Raf or PI3K, whereas the T35S mutation retains
Raf but not PI3K or RalGEF binding (Rodriguez-Viciana et al.,88 Developmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier In1997; White et al., 1995). We generated otherwise WT animals
harboring transgenes driving VPC-specific expression of let-60
(12V) (general gf) or let-60(12V,35S) (Raf gf). As expected, both
transgenes caused a Raf-dependent hyper-induced phenotype
(Figures S3E and S3F). In contrast transgenic VPC-expressedc.
Developmental Cell
Ral in Vulval Patterninglet-60(12V,37G) (RalGEF gf) suppressed the hyper-induced
phenotype of let-60(gf) animals compared to nontransgenic
siblings (Figure 3G), equivalent to the effect of ral-1(gf) (above)
and consistent with RalGEF-selective activity. Control VPC-
specific expression of let-60(+) in the let-60(gf) background
caused no phenotype (data not shown).
Although the H-Ras(12V,37G) effector-binding mutant is
impaired in its ability to activate PI3K and Raf, the mutant protein
still retains the ability to bind other Ras-binding proteins in addi-
tion to RalGEF (Kelley et al., 2001). However, we showed that the
LET-60(12V,37G) phenotype is entirely RGL-1 andRAL-1 depen-
dent (Figure 3G), suggesting that the LET-60(12V,37G) pheno-
type is not due to signaling through other effectors. Thus, we
conclude that Ras can signal through RalGEF in vulval fate
specification.
In mammalian cells Ras is thought to be the exclusive small
GTPase activator of RalGEFs, but in Drosophila the Rap family
of Ras-related small GTPases has been implicated in RalGEF
activation (Mirey et al., 2003; Rodriguez-Viciana et al., 2004).
Our results argue that in the vulva, it is Ras that signals through
RalGEF, but we also tested vulval function of characterized
C. elegans Rap proteins. Injected rap-1(RNAi) or rap-2(RNAi)
failed to enhance the let-60(gf) phenotype (data not shown), sug-
gesting that Raps are not required for the RGL-1-RAL-1 signal.
Previously, RAL-1 was shown to function redundantly with the
Rap ortholog RAP-1 in essential epithelial morphogenesis,
whereas loss of both rap-1 and rap-2 is synthetic lethal (Frische
et al., 2007; Pellis-van Berkel et al., 2005). For these reasons
Raps were not more extensively analyzed, but multiple lines of
evidence argue that Ras activates RGL-1-RAL-1 in vulval devel-
opment as a bona fide vulval signaling module.
RAL-1 Cooperates with Notch to Specify 2 Vulval Fate
1 and 2 fates are mutually antagonistic, such that loss (or gain)
of one pathway boosts (or suppresses) the other. In this context
there are two interpretations of our data thus far. First, Ras-Ral-
GEF-Ral could be an anti-1 pathway that impinges on the pro-1
pathway downstream of the LIN-1 and LIN-31 transcription
factors. Second, Ras-RalGEF-Ral could function as an alterna-
tive signaling output of the EGF signal to promote 2 fate, thus
finally providing a mechanism for the morphogen gradient
model. This second model is consistent with the described
mutual 1 versus 2 antagonism in conjunction with our observa-
tions, as follows. First, loss of a pro-2 signal (e.g., loss of rgl-1
and ral-1) should enhance the pro-1 activity of let-60(gf).
Second, activation of a pro-2 signal (e.g., ectopic-activated
RAL-1 or RalGEF-selective Ras), should suppress the pro-1
activity of let-60(gf). Third, loss of a pro-2 signal (e.g., loss of
let-60, rgl-1 and ral-1) in the ERK-independent hyper-induced
transcription factor mutants should enhance their hyper-induced
phenotypes. Therefore, we hypothesize that Ras-RalGEF-Ral
promotes 2 fate, but our experiments thus far have only exam-
ined Ras, RalGEF, and Ral function in pro-1 assays.
To evaluate the second model, we used sensitized dominant-
activated (d) LIN-12/Notch backgrounds. lin-12(n302d) and lin-
12(n379d) mutant animals have two features critical for our
study. First, they lack an AC, the source of EGF. Second, their
activated pro-2 signal is relatively weak and, thus, sensitive to
further stimulation (Greenwald et al., 1983). Importantly, becauseDevethere is no AC, the Notch activity assayed is likely to be LIN-3/
EGF independent. VPC-specific expression of activated ral-1
(gf) significantly enhanced lin-12(d) excess 2 cell phenotypes
(Figures 4A–4C; Figure S4A). Ectopic ral-1(gf) also enhanced
glp-1(q35d)/+ (Figure S4B);glp-1 encodes the secondC. elegans
Notch receptor (Mango et al., 1991). Therefore, RAL-1 is suffi-
cient to promote Notch pro-2 activity.
Additionally, expression of a RalGEF-selective LET-60
(12V,37G) transgene, described above, in the lin-12(n302d)
background was sufficient to drive 2 fates, and this activity
was entirely rgl-1- and ral-1 dependent (Figure 4D). We note
that as predicted from the 1 versus 2 mutual antagonism,
LET-60(12V,37G) transgenes confer opposite effects in let-60
(n1046gf) pro-1 (Figure 3G) versus lin-12(d) pro-2 backgrounds
(Figure 4D). As an alternative test of this same principle, we con-
structed a strain containing lin-12(n379d), let-60(n1046gf), and
the lin-45/Raf loss-of-function mutation, n2506. In this strain
LET-60/Ras was active, but Raf pro-1 signaling was abrogated.
We observed strong Ras-dependent enhancement of the lin-12
(d) 2 induction, and this effect was significantly suppressed by
ral-1(RNAi) (Figure 4E). Thus, Ras is sufficient to drive 2 fate,
and Ras requires RalGEF and Ral for this activity.
To determine whether RAL-1 is also necessary for LIN-12/
Notch function, we used ral-1(RNAi) in weakly activated lin-12
(n302d) and lin-12(n379d)mutant animals, as well as the moder-
ately activating lin-12(n676d) and strongly activating lin-12
(n950d) and lin-12(n952d) mutant animals. In no case did we
observe ral-1(RNAi) suppression of the lin-12(d) excess 2
phenotype (data not shown). This result is expected if RAL-1 is
required only for the EGF pro-2 signal, and not the Notch pro-
2 activity per se, and thus, loss of RAL-1 had no consequences
in the absence of EGF signal.
To evaluate this model further, we determined RAL-1 neces-
sity for LIN-12/Notch pro-2 function under EGF-dependent
conditions. A lin-12/Notch hypomorphic allele (rf) confers mildly
compromised 2 induction, yet the AC is still present, and a single
vulval invagination forms (Sundaram and Greenwald, 1993). In
this background, ral-1(RNAi) caused modest but significant los-
ses of 2 lineages and increased morphogenetic defects (Fig-
ure 4F). We propose that ral-1 is necessary for full LIN-12/Notch
pro-2 activity, but only under EGF-dependent conditions.
Together, these observations suggest that Ras-RalGEF-Ral
mediates an EGF signal that promotes 2 fate, and we tested
this hypothesis.
EGF Levels Insufficient for 1 Induction Can Induce
2Fate through Ras and Ral
EGF was shown previously to be sufficient to induce 2 cells in
the absence of neighboring 1 cells, arguing that there exists
an EGF pro-2 signal (Katz et al., 1995, 1996; Sternberg and
Horvitz, 1986, 1989). To examine a putative RAL-1 function in
propagating the pro-2 EGF signal, we used two reagents to
develop a robust EGF pro-2 signaling assay. First, lin-12
(n379d), described above, is a weakly activating Notch mutation
that abolishes AC development in 90% of animals and weakly
induces an ectopic 2 phenotype (Greenwald et al., 1983).
Second, to titrate EGF levels with temperature, we added to
the lin-12(d) background the temperature-sensitive lin-15
(n765ts)mutation, which at 15C caused no ectopic 1 inductionlopmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier Inc. 89
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Figure 4. Ras-RalGEF-Ral Promotes Pro-2Fate
(A and B) DIC micrographs of late L4 stage (A) lin-12(n302d) and (B) lin-12(n302d) + ral-1(Q75L) animals. Arrows indicate ectopic 2 cells. Anterior is left, and
ventral is down. (C) Transgenic-activated RAL-1(Q75L) enhanced 2 cell induction of activated lin-12(n302d). Two transgenes were assayed four times each.
(D) Transgenic-activated LET-60(12V,37G) (RalGEF selective) enhanced lin-12(n302d) compared to nontransgene-bearing siblings and was RGL-1 and RAL-1
dependent. Two transgenes were assayed three times each. (E) Endogenous activated LET-60 (let-60(n1046gf)) with blocked LIN-45/Raf (lin-45(n2506rf))
enhanced lin-12(n379d) and was RAL-1 dependent. Data shown are representative of three independent assays. y axis is the number of VPCs induced to vulval
(1 and 2) fates (C and D) or total vulval invaginations (E). Data are the mean ± SEM. For statistical reasons single nonpooled assays are shown, and white
numbers represent animals scored therein. (F) The lin-12(n137n460rf) temperature-sensitive hypomorph is sensitive to loss of RAL-1. ral-1(RNAi) caused signif-
icant loss of 2 lineages and increased incidence of morphologically abnormal vulvae. We observed double 2 loss in ral-1(RNAi) but not gfp(RNAi) controls, and
thus, loss of ral-1was qualitatively different. Results are from three pooled assays (*p < 0.05, **p < 0.01, ****p < 0.0001). Statistics were calculated byMann-Whit-
ney test (C), Kruskal-Wallis, Dunn test (D and E), or Fisher’s exact test (F).
See also Figure S4.
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Ral in Vulval Patterningbut at 25C is strongly hyper-induced via ectopic EGF expres-
sion. lin-15 encodes components of a transcriptional regulatory
complex that represses LIN-3/EGF expression outside of the
AC, in the epithelia surrounding the VPCs (Cui et al., 2006).
We compared the lin-12(d); lin-15(ts) double-mutant to lin-12
(d) and lin-15(ts) single-mutant strains from 15C to 18C (Fig-
ure 5A). lin-12(d) is not temperature sensitive; at all temperatures
10% of animals had a normal AC/vulva, and animals averaged
0.4 ectopic invaginations that we judged to be 2 based on90 Developmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier Inmorphological criteria (the distal 2 lineage cells adhere to the
cuticle, whereas the proximal cells invaginate) (Katz et al.,
1995). In lin-15(ts) single-mutant animals, we observed no and
rare ectopic vulval induction at 15C and 16C, respectively;
however, because all animals had an AC, they formed normal
vulvae. But lin-15(ts) ectopic induction greatly increased at
17C and 18C, and these invaginations contained combined
1 and 2 lineages typical for ectopic pro-1 signaling. To better
contrast the lin-15(ts) single-mutant ectopic pro-1 phenotypec.
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Figure 5. ral-1-Dependent EGF and EGFR
Signaling Is Sufficient for Pro-2 Activity
(A) A comparison of lin-12(n379d) alone (black
bars), lin-12(n379d); lin-15(n765ts) (gray bars),
and lin-15(n765ts) alone (red bars), all grown on
gfp(RNAi). Animals were grown at 15C, 16C,
17C, or 18C. Total vulval invaginations (left,
black y axis for black and gray columns) or ectopic
pseudo vulval invaginations (right, red y axis for
red columns) were scored. (B) RNAi of lin-3/EGF,
let-60/Ras, or lin-12/Notch suppressed invagina-
tions induced by lin-12(n379d); lin-15(n765ts) at
16C, and lin-45(RNAi) enhanced. Data shown
are representative of three independent assays.
(C) ral-1(RNAi) or lin-12(RNAi) suppressed
invaginations induced by lin-12(n379d); lin-15
(n765ts) at 16C. Data shown are representative
of three independent assays. (D) Activated let-23
(sa62gf)/+ (moderately activated EGFR) enhanced
invaginations induced by lin-12(n379d) in
a LET-60- and RAL-1-dependent manner. Data
shown are representative of three independent
assays. y axis is the number of total vulval invagi-
nations at 16C (B and C) or 23C (D). Data are the
mean ± SEM. For statistical reasons single, non-
pooled assays are shown, and white numbers
represent animals scored therein. Statistics were
calculated by Mann-Whitney test (A) or Kruskal-
Wallis, Dunn test (B–D). (E and F) Ectopic vulval
cells induced at 16C by lin-15(ts) in the lin-12
(n379d) background are 2. (E) DIC and (F) epi-
fluorescent images of mgIs21(Plin-11::gfp+rol-6
(d)); lin-12(n379d); lin-15(n765ts). Nineteen of 20
ectopically induced VPCs expressed the lin-11
2 fate marker.
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Ral in Vulval Patterningwith the double-mutant lin-12(d); lin-15(ts) pro-2 phenotype,
below, we show only ectopic pseudo vulvae induced in the lin-
15(ts) single-mutant background, and excluded WT vulvae (Fig-
ure 5A, red).
Strikingly, in the double-mutant strain we observed strong
synergy at 15C and 16C (p < 0.00001 for both), temperatures
at which lin-15(ts) alone was not sufficient to induce ectopic 1
invaginations (Figure 5A). By morphology these excess invagi-
nations were 2, indicating that subthreshold EGF activity in
a sensitized background induced large numbers of 2 cells. To
verify that the observed lin-15(ts) effect was EGF dependent,
we targeted lin-3/EGF with RNAi and observed suppression of
lin-15(ts) synergistic phenotypes (Figure 5B). Including the
mgIs21 lin-11 promoter::GFP fusion transgene in the lin-12(d);
lin-15(ts) strain as a reporter of 2 fate verified that these ectop-
ically induced cells were mostly 2 cells (Figures 5E and 5F).
Thus, we demonstrated that the putative EGF pro-2 signal
cooperates with the Notch pro-2 signal to specify 2 fate,Developmental Cell 20, 84–96a property predicted to increase fidelity
of vulval patterning. Furthermore, we
have precisely controlled EGF input into
2 fate induction.
A parsimonious working model posits
that in presumptive 2 cells, EGF-acti-
vated Ras signals preferentially throughRGL-1 rather than Raf. A prediction of this model is that LET-
60/Ras and RAL-1 activities are necessary for full LIN-3/EGF
pro-2 signaling output. Our system for studying this EGF-
signaling property allowed us to analyze sufficient numbers of
animals to evaluate our model. We subjected lin-12(d); lin-15
(ts) animals grown at 16C to let-60- (Figure 5B) or ral-1-directed
RNAi (Figure 5C). Importantly, loss of both let-60 and ral-1
suppressed the level of 2 hyper-induction, as did loss of lin-12
in the control experiment. As an internal control for lin-12(RNAi)
efficacy, we observed dramatic suppression of the lin-12(d)
absent-AC defect (from 13.2% with gfp(RNAi) to 76.5% with
lin-12(RNAi)) (data not shown).
We also performed lin-45(RNAi) in this background and found
that loss of LIN-45/Raf enhanced 2 fate induction, consistent
with the pro-1 function of Ras-Raf (Figure 5B). We hypothesize
that naive presumptive 2 VPCs activate both Raf and RalGEF in
response to EGF signal, such that loss of the antagonistic Raf
derepresses general pro-2 signaling., January 18, 2011 ª2011 Elsevier Inc. 91
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Figure 6. Pral-1::gfp Is Dynamically Expressed during Early Vulval Development
Before induction, Pral-1::gfp (NLS+) is expressed in all VPCs but first is restricted to EGF-induced presumptive 1
 and 2 VPCs, and then to 2 cells only.
(A) Early Pn.p stage before induction.
(B) Mid Pn.p stage. The background glow is strong excretory canal expression. The P7.p nucleus was GFP positive but was out of the plane of focus.
(C) Late Pn.p stage with absent P6.p expression.
See also Figure S5.
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(d); lin-15(ts) phenotype with an activating mutation in LET-
23/EGFR. Previously it was shown that let-23(sa62gf)/+ animals
induced 2 and 3 fate in isolated VPCs without an AC,
whereas sa62/sa62 conferred mostly 1 fate (Katz et al.,
1996). We found that let-23(sa62gf)/+; lin-12(n379d) had more
2 cells than lin-12(n379d) alone, and this effect was sup-
pressed by let-60(RNAi) or ral-1(RNAi) (Figure 5D). Together,
these data indicate that the Ras-RalGEF-Ral pathway mediates
the EGF pro-2 signal.Regulation of RAL-1 Expression Provides a Mechanism
for Effector Switching
Transgenic embryos harboring a ral-1 promoter-driven gfp
fusion construct showed broad embryonic GFP expression.
Post-embryonically, GFP was observed in excretory canals,
a small number of neurons, and was expressed dynamically in
vulval lineages. Prior to EGF induction, GFP was expressed in
all VPCs, but at the time of induction, GFP was restricted to
P5.p, P6.p and P7.p, cells receiving the EGF signal (Figures 6A
and 6B). Soon thereafter expression was extinguished in the
presumptive 1 cell (P6.p), persisted strongly in presumptive
2s (P5.p and P7.p), and was faintly restored in presumptive
3s (Figure 6C). Further dynamic expression changes were
seen in later vulval development, after fate specification
(Figure S5).
We show that LET-60/Ras switches effectors from pro-1 LIN-
45/Raf output in presumptive 1 cells to pro-2 RGL-1-RAL-1
output in presumptive 2 cells. We hypothesize that the mecha-
nism of effector switching contains two components. First, RAL-
1 expression following initial induction is quickly restrictedmainly
to presumptive 2s, and therefore, persistent Ras pro-2
signaling is limited to presumptive 2 cells. Second, concordant
restriction to presumptive 2 cells of LIP-1/ERK phosphatase
quenches the ERK signal. Thus, soon after initial induction, the
predominant Ras effector output in presumptive 2 cells is
RGL-1-RAL-1.92 Developmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier InThe early vulval RAL-1 expression pattern mirrors that of LIP-1
(Berset et al., 2001), indicating that both RAL-1 and LIP-1 are
precociously present to influence interpretation of the initial
EGF inductive signal to naive VPCs. If so, in presumptive 1 cells
the Ras-RalGEF-Ral pro-2 response to EGF is expected to
conflict with the Ras-Raf pro-1 response. Likewise, in presump-
tive 1 cells the Ras-Raf pro-1 response should be blunted by
early LIP-1/ERK phosphatase expression. Therefore, rapid tran-
scriptional exclusion of both LIP-1 and RAL-1 proteins from the
presumptive 1 cell facilitates maximal Ras-Raf pro-1 activity.
Supporting this model, rgl-1(RNAi) or ral-1(RNAi) suppressed
the under-induced phenotype conferred by rf in lin-3/EGF or
let-23/EGFR (Figures S2D and S2E), and comparable suppres-
sion was observed with loss of LIP-1 (Berset et al., 2001). We
argue that loss of RAL-1 or LIP-1 strengthens the initial pro-1
inductive event in presumptive 1 cells and, thus, rescues
compromised EGF pro-1 signaling. Hence, RAL-1 and LIP-1
cooperate as a programmed switch to toggle Ras output from
Raf to RGL-1 in presumptive 2 cells.DISCUSSION
RGL-1-RAL-1 Provides a Mechanistic Key to
Interpretation of the EGF Morphogen Gradient
The continually expanding number of functionally diverse effec-
tors raises the issue of how Ras signaling output is controlled
through dynamic spatial and temporal effector utilization to
orchestrate its complex biology in normal and neoplastic cells.
We describe mechanisms whereby a balance of redirected
effector signal output and pathway quenching can bring two
antagonistic pathways into harmony, with each faithfully
promoting divergent fates in response to the same initial
patterning signal. This general patterning reinforcement/fidelity
mechanism may prove to be widespread in metazoan
development.
The molecular mechanisms of EGF induction of 1 fate and
consequent 1-dependent Notch induction of 2 fate are wellc.
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Figure 7. EGF Signaling through Ras Uses Effector
Switching to Induce Opposing Vulval Fates
Signal promoting both fates is shown in green, pro-1 signal in
blue, pro-2 signal in red, and quenched signals in gray. A
putative EGF concentration gradient, in combination with
sequential induction, faithfully patterns vulval fates. In
presumptive 1 cells, EGF activates Ras to utilize Raf to
promote 1 cell fate. Pro-2 signaling through Notch is
quenched. Putative quenching of RGL-1-RAL-1 pro-1
activity is based on RAL-1 exclusion from presumptive 1
cells. Presumptive 1 cells produce DSL ligands to induce
neighboring VPCs via Notch to assume 2 fate. In presumptive
2 cells, Notch induces production of LIP-1/ERK phosphatase
and other 2-specific proteins to quench the Raf pro-1 signal.
Also, EGF activates Ras to utilize RGL-1-RAL-1 to promote 2
fate. Thus, the EGF signal toggles its developmental output by
Ras effector switching.
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Ral in Vulval Patterningcharacterized. Additionally, a graded EGFR signal has been
shown to exist, but direct EGF signaling from the AC is sufficient
but not necessary for 2 fate induction (Koga and Ohshima,
1995; Simske and Kim, 1995). The mechanism by which the
pro-2 EGFR signal is propagated was previously unknown.
We incorporate the insights from our study of Ral signaling into
a new model in which we reconcile prior models of graded
morphogen signaling, sequential induction, and signal quench-
ing (Figure 7). We mechanistically validated the ‘‘graded
morphogen model’’ and show that Ras effector switching serves
to emphasize the antagonistic relationship between Ras and
Notch. In the AC-proximal VPC (P6.p), EGF activates Ras and
the ERK MAPK cascade to induce 1 fate, which by stimulating
production of Notch ligands in turn induces 2 fate in neighboring
VPCs. In presumptive 2 cells the Raf pro-1 signal is rapidly
quenched by 2-specific expression of LIP-1/ERK phosphatase
(Berset et al., 2001) and other negative regulators (Berset et al.,
2005; Yoo et al., 2004; Yoo and Greenwald, 2005). Instead, Ras
signals through RGL-1 to promote 2 fate. Thus, the utilization of
the RGL-1-RAL-1 signaling module is a critical feature of the
differential response of cells across the EGF gradient. Such
pathway interweaving may result in developmental fidelity and
robustness of vulval patterning (Braendle and Felix, 2008).
Loss of LET-60/Ras or RAL-1 suppressed the induction of 2
cells by lin-12(d); lin-15(ts) at 16C and the induction of 2 cells
by let-23(sa62gf)/+; lin-12(d), but only partially. Therefore, we
speculate that Ras-RGL-1-RAL-1 comprises only part of the
pro-2 EGF signal. We note that additional EGF pro-2 signaling
activity may be Ras independent and is perhaps engaged
directly by activated EGFR.
Morphogen gradients have been studied for decades, yet
there are still significant mysteries in differential interpretationDevelopmental Celof signals across gradients (Lawrence, 2001). In
other systems a variety of gradient responsemech-
anisms exists, from differential transcription of
target genes to signal-induced reprogramming of
signal response (Ibanes and Izpisua Belmonte,
2008; Piddini and Vincent, 2009), but correlation
and causation are not always clear in these
systems. In cultured human cells exposed to
ectopic EGF or heregulin ligand, downstreampathway utilization varies dramatically by cell line, time of expo-
sure, and ligand concentration (Chen et al., 2009). In vulval
patterning, EGF gradient input is superimposed on sequential
EGF and Notch signals, and our results suggest that Ras effector
switching comprises a significant portion of EGF gradient
interpretation.
Effector Switching Achieves Divergent Developmental
Outcomes from the Same Signal
Our results indicate that Ras switches effector utilization
between presumptive 1 and 2 cells by restricting RAL-1
expression to presumptive 2 cells. It is unknown how this 2-
specific RAL-1 transcriptional expression is patterned, but we
hypothesize a combination of ERK pro-1 and Notch pro-2 tran-
scriptional outputs. However, unlike the promoters of 2-specific
Notch-responsive lst genes, the promoter of ral-1 lacks concen-
trated conserved Notch-responsive sequence elements (data
not shown). If past studies are an indicator, there are likely to
be multiple overlapping systems that cooperatively reprogram
EGF output.
Clearly, LIN-45/Raf effector pathway quenching is also critical
because there are significant consequences of loss of LIP-1/
ERK phosphatase (Berset et al., 2001). Based on our GFP
expression studies, we speculate that a similar quenching
phenomenon may exist for RAL-1 at the transcriptional level
because a ral-1 reporter is rapidly excluded from presumptive
1 cells after initial induction. Thus, RAL-1 quenching occurs in
presumptive 1 cells and is complementary to Ras-Raf-ERK
quenching in presumptive 2 cells.
Theoretically, effector switching can also occur at the level of
Ras effector binding. Loss of the C. elegans SOC-2/SUR-8
(human Shoc2) diminishes Ras-Raf signaling (Selforsl 20, 84–96, January 18, 2011 ª2011 Elsevier Inc. 93
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Ral in Vulval Patterninget al., 1998; Sieburth et al., 1998). Shoc2 physically scaffolds Ras
and Raf, thus regulating Ras-Raf association and pathway acti-
vation (Li et al., 2000). Although no such protein has been iden-
tified for Ras-RalGEF scaffolding, dynamic developmental regu-
lation of such scaffolds could critically impact effector usage.
Previous studies of PC12 pheochromocytoma cell differentia-
tion suggested that, via differential effector usage, divergent
developmental outcomes arise from a particular signal. Nerve
growth factor activation of Ras promotes Raf- and PI3K-depen-
dent neuronal differentiation and growth cessation (Jackson
et al., 1996; Sano and Kitajima, 1998). Conversely, Ras activation
of RalGEF promotes proliferation, and not differentiation
(Goi et al., 1999). Thus, Ras has the potential to promote both
pro-differentiation and anti-differentiation by engaging different
effectors in the same cell type. In PC12 cells, RalGEF is specu-
lated to be eventually uncoupled from Ras (Goi et al., 1999).
Thus, whereas the potential for effector switching has been
demonstrated in cell culture, mechanisms of pathway interaction
are lacking.
The Ras-RalGEF parallelism to Ras-Raf was foreshadowed by
a previous Drosophila study (Karim and Rubin, 1998). Also in
Drosophila, activated Ras phenotypes were enhanced by a Ral
dominant negative, consistent with the antagonistic Ras-Raf
and Ras-RalGEF activities described here (Mirey et al., 2003).
The use of multiple Ras effectors in parallel in the same develop-
mental event may explain these puzzling results, or the relation-
ship among Ras, Ral, and Rap small GTPasesmay be different in
different developmental contexts.
Interplay between Notch and Ras signaling is a common
theme in developmental biology, and Notch and Ras interplay
is also observed in mouse pancreatic cell differentiation and
cancer development (Mysliwiec and Boucher, 2009; Sundaram,
2005). Whether this pancreatic Ras-Notch interplay depends on
K-Ras activation of the RalGEF-Ral pathway is not known, but it
is intriguing that RalGEF, but not Raf, is preferentially activated in
pancreatic cancer cells, and Ral activation is necessary for
pancreatic cancer growth (Lim et al., 2005, 2006).
Efforts to develop anti-Ras inhibitors have focused on target-
ing effector signaling (Yeh and Der, 2007) and have been compli-
cated by cell- and cancer-type differences in effector depen-
dency and activation (Hamad et al., 2002; Lim et al., 2005;
Rangarajan et al., 2004; Tuveson et al., 2004). How differential
effector utilization and activation are achieved remains an
unresolved issue. Our observations establish one mechanism
for this phenomenon. Additional mechanisms may involve regu-
lation of the subcellular localization of Ras to distinct membrane
compartments, leading to spatial regulation of effector activation
(Bivona et al., 2006; Onken et al., 2006).
In conclusion we demonstrate a patterning role for Ras
effector switching that has implications beyond developmental
genetics. Studies in model genetic organisms in conjunction
with mouse and cell culture studies were instrumental in devel-
oping our early understanding of key signal transduction
pathways, including canonical EGF signaling through the Ras-
Raf-MEK-ERK signaling module to regulate transcription.
Recent studies in pathway quenching, and now effector switch-
ing, to promote alternative ligand outputs argue that C. elegans
vulval patterning continues to yield important insights into
diverse biological fields.94 Developmental Cell 20, 84–96, January 18, 2011 ª2011 Elsevier InEXPERIMENTAL PROCEDURES
General C. elegans Methods, Strains, Constructs, and Transgenic
Lines
Strain handling and generation of constructs and transgenic lines used stan-
dard methods (see Supplemental Experimental Procedures).
ral-1(tm2760); let-60(n1046 gf) Double-Mutant Construction
The ral-1(tm2760) deletion, kindly provided by Shohei Mitani, removes nucle-
otides 418–996 (numbered from position +1 of the ral-1 initiating ATG codon),
deleting part of the splice donor site. Single worm PCR of ral-1(tm2760) was
performed as described (Williams et al., 1992). In the initial strain isolate,
heterozygous tm2760 cosegregated with a sterile mutation. Outcrossing
tm2760 and recombination in the daf-2-dpy-17 interval failed to separate the
sterile mutation from tm2760. ral-1(RNAi) did not impact fertility, even when
performed in the eri-1(mg366) RNAi hypersensitive background (Kennedy
et al., 2004). Therefore, we hypothesize that sterility is conferred by a mutation
closely linked to ral-1(tm2760). Sterile animals formed a functional vulva, so in
the let-60(n1046gf) background we balanced ral-1(tm2760) with unc-93
(e1500sd) dpy-17(e164). We used the semidominant unc-93(e1550sd) Unc
phenotype to distinguish tm2760/tm2760 homozygotes from tm2760/unc-93
dpy-17 heterozygotes, and scored vulvas of non-Unc animals. Single worm
PCR (Tm = 53
, cycles = 35) with the primers TZ23 (CAACAAGTCGTCCAT
AAAGTG), TZ24 (GGCGAAAAACGAGAAAAGAAC), and TZ25 (GAATTTTTC
AGGCTTTCTGACG) confirmed the tm2760/tm2760 genotype of each scored
animal.
Bacterially Mediated RNA interference
Bacterially mediated RNAi was performed mostly as described (Fire et al.,
1998; Kamath et al., 2001; Timmons et al., 2001). Each feeding RNAi (fRNAi)
clone was sequenced to confirm identity. Eighty microliters of bacteria was
seeded on NGM agar plates containing 1 mM IPTG and 50 mg/ml carbenicillin.
L4 larvae were added to the plates the following day. After 24 hr, animals were
transferred to new plates, and parents were removed after an additional 24 hr.
We consistently obtained stronger fRNAi phenotypes at 23C, and thus, all
fRNAi experiments were performed at 23C. gfp(RNAi) or daf-3(RNAi) was
used as a control. pop-1(RNAi) was included in all experiments as a positive
control for RNAi efficacy. Phenotypes were only scored if we observed
100% lethality on the pop-1(RNAi) plates.
Vulval Induction Assay
Late L4 hermaphrodites were mounted as described previously in 5 mM
sodium azide/M9 buffer on slides with agar pads. L4 vulval invaginations
were visualized under DIC Nomarski optics (Sternberg and Horvitz, 1986;
Sulston and Horvitz, 1977). Images were captured using a Nikon Eclipse
E800 microscope with a Hamamatsu C2400-07 Newvicon camera controlled
by MetaMorph acquisition software (Molecular Devices). WT animals scored
3.0 (three induced VPCs). Values greater than 3.0 indicated hyper-induction,
less than 3.0 under-induction.
Fluorescence Microscopy
Live animals were mounted in 2 mg/ml tetramisole/M9 buffer on slides with
agar pads and visualized using a Nikon Eclipse TE2000U microscope equip-
pedwith a DVC-1412CCDcamera (Digital Video Camera Company) controlled
by the Hamamatsu SimplePCI acquisition software.
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